Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ESCITALOPRAM OXALATE
Chanelle Healthcare Limited
20 Base mg/ml
Oral Drops Solution
2012-03-23
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Escitalopram 20mg/ml Oral Drops Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains: 20 mg escitalopram (as 25.56 mg escitalopram oxalate). Each drop contains 1 mg of escitalopram. Excipients: Each drop contains 4.7mg of ethanol. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral drops, solution A clear solution with a bitter taste. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of major depressive episodes. Treatment of panic disorder with or without agoraphobia. Treatment of social anxiety disorder (social phobia). Treatment of generalised anxiety disorder. Treatment of obsessive-compulsive disorder 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Safety of daily doses above 20 mg (20 drops) has not been demonstrated. _Major depressive episodes_ Usual dosage is 10 mg (10 drops) once daily. Depending on individual patient response, the dose may be increased to a maximum of 20 mg (20 drops) daily. Usually 2-4 weeks are necessary to obtain antidepressant response. After the symptoms resolve, treatment for at least 6 months is required for consolidation of the response. _Panic disorder with or without agoraphobia_ An initial dose of 5 mg (5 drops) is recommended for the first week before increasing the dose to 10 mg (10 drops) daily. The dose may be further increased, up to a maximum of 20 mg (20 drops) daily, dependent on individual patient response. Maximum effectiveness is reached after about 3 months. The treatment lasts several months. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 28/03/2012_ _CRN 2099216_ _page number: 1_ _Social anxiety disorder_ Usual d Read the complete document